MAPT and Alzheimer disease: Thus, we speculate that activation of GSK-3β resulting from insulin resistant in AD brain one hand causes hyperphosphorylation of tau, other hand may increase PP2A methylation through PME-1, resulting in the attenuation of hyperphosphorylation of tau.